missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Ranitidine Related Compound A Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR1773100MG
Description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Ranitidine Related Compound A is an impurity of ranitidine, an inhibitor of gastric acid secretion. Ranitidine is widely used for treating gastric and duodenal ulcers.Specifications
| 91224-69-0 | |
| C10H18N2 OS · 0.5 C4H4O4 | |
| Certified Reference Material | |
| 272.36 |
| These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. | |
| 2-{{{5-[(Dimethylamino)methyl]furan-2-yl}methyl}sulfanyl}ethanamine hemifumarate salt; 2-{{{5-[(DIMETHYLAMINO)METHYL] FURAN-2-YL}METHYL}SULFANYL} ETHANEAMINEHEMIFUMARATE SALT; Ranitidine Impurity B; 2-{{{5-[(Dimethylamino)methyl]-2-furanyl}methyl}thio}ethylamine hemifumarate salt; 5-{[(2-Aminoethyl)thio]methyl}-N,N-dimethyl- 2-furanmethanamine hemifumarate salt; Ranitidine diamine hemifumarate salt | |
| 100 mg | |
| Certified Reference Material |